H. Lundbeck A/S
Budget
€25 — €0
EP Access
0
accredited persons
Staff
3
0.3 FTE
EU Grants
None
Mission & Goals
H. Lundbeck A/S is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research. We are dedicated to advancing brain health and transforming lives. We have approx. 5,000 employees in 27 countries and products available in more than 80 countries Our research programs tackle some of the most complex challenges in neuroscience, and our pipeline is focused on bringing forward transformative treatments for brain diseases for which there are few, if any therapeutic options. We have research facilities in Denmark and the United States, and our production facilities are located in Denmark, France and Italy. Lundbeck generated revenue of DKK 22 billion in 2024.
EU Legislative Interests
MFN Brain health and innovation proposals and policies EU pharma legislation Urban Waste Water Directive Other
Communication Activities
Europe's Choice
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
EFPIA - European Federation of Pharmaceutical Industries and Associations http://www.efpia.eu/ DI - Confederation of Danish Industry http://di.dk/English/Pages/English.aspx LIF - Danish Association of the Pharmaceutical Industry https://www.lif.dk/ EBC- European Brain Council http://www.europeanbraincouncil.org/
Organisation Members
-
Additional Information
-
Commissioner Meetings
No recorded meetings with EU commissioners.